Minerva IPO Presentation Deck
Offering Summary
Issuer (Exchange / Ticker):
Base Offering Size:
Shares Offered:
Overallotment Option:
Filing Range:
Lock-up Period:
Use of Proceeds:
Joint Bookrunners:
Stabilization Agent:
Expected Pricing:
Minerva Surgical, Inc. (Nasdaq / UTRS)
$100 million (100% primary, at the midpoint of the range)
6,250,000 shares (100% primary)
937,500 shares (100% primary, 15% of base deal)
$15-$17 per share
180 days for the Company, directors, executive officers, affiliates and substantially all security holders
The Company currently expects to use the net proceeds from this offering to:
• meet deferred payment obligations and potential milestone payments to Boston Scientific Corporation (BSC);
expand sales force and operations;
research and development; and
• working capital and general corporate purposes
J.P. Morgan, Piper Sandler, UBS Investment Bank, SVB Leerink
J.P. Morgan
October 21, 2021
3View entire presentation